Irene Marco RiusJunior Group Leader
Molecular Imaging for Precision Medicine
+34 93402 45 84
Her research develops tools based on magnetic resonance spectroscopy (MRS) and imaging (MRI) to gain insights on cellular metabolism and detect pathological changes, in order to identity biomarkers of disease for an early diagnosis and to evaluate treatment response short after therapy administration.
Particularly, she has experience in the use of hyperpolarisation by dynamic nuclear polarisation to study disease in vivo, in real time and non-invasively.
Irene's team has currently three main research lines:
· Biomarker discovery in in vivo and in vitro models of diseases.
· MRS hardware and software development to monitor disease and evaluate drug response in situ, in organ-on-chip models.
· Metabolomic studies of clinical samples and body fluids ex-vivo.
She is a strong advocate of fostering scientific careers and the importance of science communication. She takes an active role in teaching and mentoring younger scientist from school age to PhD students, delivering talks on career development and talking to the public about her work.